Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

deCODE discovers gene in obesity alliance with Merck

Oct. 2, 2003

Lilly scientists design new PPARalpha/PPARgamma modulators

Oct. 2, 2003

New inhibitors of dipeptidyl-peptidase IV with blood glucose-lowering activity

Sep. 30, 2003

French team prepares and tests new insulin mimetics

Sep. 30, 2003

Guanidine-based melanocortin MC4 agonists covered by Chiron patent

Sep. 30, 2003

New neuropeptide Y5 receptor antagonists described by Roche

Sep. 29, 2003

Gemcabene improves lipid profile of patients with low serum HDL cholesterol levels

Sep. 29, 2003

Kissei patents new thyroid hormone receptor ligands

Sep. 26, 2003

RPR-749 is safe and lowers FFA levels in first human trial

Sep. 25, 2003

Dainippon scientists prepare and test novel glucagon antagonists

Sep. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...